XML 54 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2
Shareholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 6 Months Ended
Sep. 14, 2020
Jan. 10, 2017
May 01, 2016
Sep. 16, 2020
Jun. 30, 2022
Jun. 30, 2021
Shareholders' Equity (Details) [Line Items]            
ordinary shares are available for future grants (in Shares)         5,096,958  
Unrecognized compensation expense         $ 15,258  
Weighted average vesting period         3 years 5 months 19 days  
Weighted average fair value of shares vested (in Dollars per share)         $ 53  
Weighted average fair value of shares forfeited (in Dollars per share)         $ 67.45  
Warrants to purchase ordinary shares (in Shares) 3,401,060          
Exercise price (in Dollars per share) $ 59.26          
Vesting payments $ 5,000   $ 5,000      
Class of warrant exercisable (in Shares)       2,162,463 1,088,332  
Ordinary shares received exercise (in Shares)       1,689,942    
Purchased products and services $ 400,000          
Recognized reduction revenues         $ 12,521 $ 9,711
Master Purchase Agreement [Member]            
Shareholders' Equity (Details) [Line Items]            
Warrants to purchase ordinary shares (in Shares)   2,932,176        
Exercise price (in Dollars per share)   $ 13.04        
Payments for purchased products and services     $ 150,000      
Class of warrant exercisable (in Shares)         769,692  
Restricted Stock Units [Member]            
Shareholders' Equity (Details) [Line Items]            
Options exercisable, description         The terms of option grants generally provide that 25% of total options are exercisable one year after the grant or vesting start date determined for each optionee and a further 6.25% is exercisable at the end of each subsequent three-month period over the following 3 years. Options are exercisable for up to 10 years from the grant date. Options that are cancelled or forfeited before expiration become available for future grants.   
Weighted average vesting period         4 years  
Unrecognized compensation expense         $ 45,073  
Weighted average vesting period         2 years 10 months 24 days  
Weighted average fair value of options granted (in Dollars per share)         $ 82.02